From: Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction – a randomised placebo-controlled trial (KARE): study protocol
Outcome
Value in patients with acute lung injury
Detectable effect size
Respiratory compliance (ml/cmH2O)
57.8 (36.5)
27.8
Sequential organ failure assessment score
7.2 (4.2)
3.2